#United States #Pediatric Care #Wilmington #Nemours #Lisa Dean Moseley Foundation

Opening of a New Era in Pediatric Care

On March 19, 2025, in an inspirational ceremony, Nemours Children's Health announced the grand opening of the Lisa Dean Moseley Foundation Institute for Cancer and Blood Disorders. This cutting-edge facility signifies a transformative step in healthcare dedicated to children battling cancer and blood disorders in the Delaware Valley and surrounding regions.

The Moseley Foundation Institute, which commenced development in March 2023 thanks to a monumental $78 million donation from the Lisa Dean Moseley Foundation, reflects an unwavering commitment to enhancing pediatric health outcomes. With an expansive footprint of 24,000 square feet, the new 24-bed inpatient facility seamlessly integrates a family-centered design and adjacent gardens, fostering a nurturing environment for healing.

Mark R. Marcantano, JD, President of Nemours Children's Health, lauded this occasion as a major milestone, paving the way for world-class research and clinical care accessible to greater numbers of children afflicted by these serious conditions.

Infrastructure and Future Expansion

The first phase of the Moseley Foundation Institute emphasizes compassion in care, and initial services are geared toward enhancing recovery experiences. The second phase, set to unveil in October 2025, will introduce a further 19,000-square-foot Day Hospital and Infusion Center, significantly amplifying service capacities.

“Our groundbreaking facility will radically improve the health landscape for children with cancer and blood disorders—not just here, but far beyond our immediate community,” Marcantano emphasized, expressing gratitude toward the Moseley Foundation for their visionary contribution.

Enhancing Research and Treatment Options

Such a noteworthy contribution from the Moseley Foundation not only enhances immediate care but ensures the longevity and effectiveness of research initiatives. This includes:

• - An Endowed Presidential Chair: This role is dedicated to pediatric patient care and research drives, ensuring the highest priorities in clinical efforts receive robust support.
• - Focus on Sickle Cell Disease: An Endowed Chair for Sickle Cell Disease Research aims to augment efforts to address disparities within care environments, particularly for affected minority communities. The project has an established funding stream from the National Institutes of Health, bolstering a rich history of research beginning in 2016.
• - Annual Request for Proposals: The institute will manage an Endowed Laureate Program designed to encourage innovative cancer and blood disorder research through comprehensive projects.
• - International Symposiums: These events aim to showcase and promote collaboration across disciplines, inviting global researchers to share insights and advancements.

A Legacy Above and Beyond

William J. Martin, Esq., President of the Lisa Dean Moseley Foundation, celebrated the institute's creation, reflecting on how it encapsulates Mrs. Moseley's mission to improve children's health outcomes significantly. He projected that the legacy left by her and the foundation will resonate throughout the healthcare landscape, benefiting not only local patients but also children nationwide.

David C. Brousseau, MD, the Pediatrician-in-Chief at Nemours, expressed anticipation regarding the immediate impact of the institute, expressing gratitude to connect families with compassionate and high-quality care as they navigate challenging health journeys.

Over the past three decades, Nemours Children's Health has established itself as a beacon of excellence within pediatric care by:

• - Launching two fully accredited transplanted cellular therapy programs, catering to kids battling cancer and sickle cell disease.
• - Receiving the National Cancer Institute's designation as a Community Oncology Research Program, ranked highly for enrollment in funded trials.
• - Effectively tripling the identification rate of cancer predisposition syndromes through its advanced Cancer Genetics Program, addressing families’ unique histories with precision.

Conclusion

The significant opening of the Lisa Dean Moseley Foundation Institute represents a promising future for healthcare among pediatric populations grappling with cancer and blood disorders. As research and high-quality care converge at this new facility, the community anticipates substantial advancements. For further information, visit Nemours.org and explore how this initiative will reshape healthcare trajectories.

About Nemours Children’s Health

Nemours Children's Health stands as one of the largest multistate pediatric healthcare systems in the U.S., striving to revolutionize children's health through holistic, innovative practices. Founded by the legacy of Alfred I. duPont, the organization continues to champion programs that go beyond traditional healthcare approaches.

About the Lisa Dean Moseley Foundation

True to its mission, the Lisa Dean Moseley Foundation aims at supporting significant medical research endeavors. Collaborating with esteemed institutions, the foundation continuously seeks to enhance patient care through strategic investments in research and innovative practices.